Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to name North 6th Agency (N6A), an award-winning brand communications agency based in New York and Toronto, the Company’s PR agency of record (AOR).
Core services in the engagement include: United States, Canadian and International market media relations; PR content, writing and editorial support; strategic communications and messaging development; PR measurement and data reporting; event and tradeshow support; social media strategy, channel management, and content development.
Marcos Agramont, CEO of Isodiol, says “N6A’s energy, passion and work ethic is a great match for our company and leadership team, all of whom are driven by a common goal to bring the highest quality bioactive phytoceutical products to consumers across the world. We needed to find a partner that had a world-class reputation to spread the word of our mission to the masses, and we believe we have found that in N6A.”
Matt Rizetta, CEO of N6A, says “Isodiol has an incredibly powerful, meaningful and revolutionary story that underscores the health and wellness benefits of proper-hemp based products created by the best and brightest in the industry. The message behind their story is unprecedented in the cannabis pharma space, and we look forward to communicating to a range of targeted audiences across the mainstream, investor and speciality trade media communities in the United States, Canada, and abroad.”
For more information on N6A please visit www.n6a.com, or www.competeandcare.com to learn more about N6A’s “Compete and Care” culture and perks programs.
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical and nutraceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of a 99%+ pure pharmaceutical grade cannabinoid crystalline isolate derived from exempt parts of the hemp plant, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
About North 6th Agency, INC:
North 6th Agency, Inc. (N6A) is an award-winning brand communications and social media agency based in the heart of SoHo in New York City and Toronto’s financial district.
N6A’s client roster includes emerging, mid-sized and enterprise brands from more than 30 industries. N6A has been awarded several prestigious industry recognitions, including ranking in the Top 50 in more industry categories than any agency in the United States, the #1 Fastest-Growing Firm ranking in O’Dwyer’s in 2016, NY Observer Power Agency List, Digiday “Most Innovative Culture” Award finalist, and has been selected as one of the “coolest spaces at the hottest PR firms” by the New York Observer.
N6A’s “Compete and Care” culture and “Embrace the Pace” atmosphere have been lauded as one of the most rewarding, collaborative and unique to the agency world by Forbes, Monster.com, New York Post, Chief Learning Office Magazine, Entrepreneur, and others.
For more information on N6A please visit www.n6a.com, or www.competeandcare.com to learn more about N6A’s “Compete and Care” culture and perks programs.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
www.isodiol.com
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Facebook: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.
Click here to connect with Isodiol International Inc. (CSE: ISOL) to receive an Investor Presentation.

Source: isodiol.com

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement, Harvest shareholders will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held.

Halper Sadeh encourages Harvest Health shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com .

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, announced today the appointment of Cameron Wickham as a Director, Chief Executive Officer and Corporate Secretary of the Company and Ankit Gosain as Chief Financial Officer of the Company, effective May 7, 2021.

Daniel Pelchovitz, the Company’s former Chief Executive Officer, will continue with Spyder as a Director of the Company and as Chief Executive Officer of Spyder Cannabis Subco Inc., the Company’s Alcohol and Gaming Commission of Ontario (AGCO)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Niagara Falls, Ontario and has submitted two additional Retail Store Authorizations to the AGCO, and The Green Spyder Inc., the Company’s Alberta Gaming, Liquor & Cannabis (AGLC)-licensed, wholly-owned subsidiary that currently operates a cannabis dispensary in Calgary, Alberta.

Keep reading... Show less

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.

1Q 2021 Financial Highlights (Unaudited)

Keep reading... Show less

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (OTC: HRVSF) in connection with the proposed acquisition of the Company by Trulieve Cannabis Corp. (“Trulieve”) (OTC: TCNNF). Under the terms of the merger agreement, Harvest shareholders will receive 0.1170 shares of Trulieve common stock for each Harvest share that they own, representing implied per-share merger consideration of approximately $4.79 based upon Trulieve’s May 7, 2021 closing price of $40.92 . Upon consummation of the transaction, current Harvest shareholders will own only 26.7% of the issued and outstanding pro forma Trulieve shares.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Participants may access a live webcast of the presentation by going to the Upcoming Events page at thecronosgroup.com . A replay will be made available shortly following the live presentation.

Keep reading... Show less